Global Intravenous IV Solutions Market 2023-2027

Global Intravenous IV Solutions Market 2023-2027


Technavio has been monitoring the intravenous IV solutions market and is forecast to grow by USD 4011.34 mn during 2022-2027, accelerating at a CAGR of 7.11% during the forecast period. Our report on the intravenous iv solutions market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic diseases, the growing geriatric population, and the increasing demand for parenteral nutrition.

Technavio's intravenous IV solutions market is segmented as below:

By Type
  • Partial parenteral nutrition
  • Total parenteral nutrition
By Distribution Channel
  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy
By Geographical Landscape
  • Asia
  • North America
  • Europe
  • Rest of World (ROW)
This study identifies the technological advancements in iv solutions as one of the prime reasons driving the intravenous iv solutions market growth during the next few years. Also, increasing demand for home healthcare and growing investments in the healthcare sector will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the intravenous iv solutions market covers the following areas:
  • Intravenous IV solutions market sizing
  • Intravenous IV solutions market forecast
  • Intravenous IV solutions market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading intravenous iv solutions market vendors that include Amanta Healthcare Ltd., Axa Parenterals Ltd., Baxter International Inc., Fresenius SE and Co. KGaA, Grifols SA, ICU Medical Inc., JW Pharmaceutical Corp., Lxir Medilabs Pvt. Ltd., MITS Healthcare Pvt. Ltd., Pfizer Inc., Salius Pharma Pvt. Ltd., Schwitz Biotech, Sichuan Kelun Pharmaceutical Co. Ltd., Soxa Formulations and Research Pvt. Ltd., Terumo Group, Vifor Pharma Management Ltd., Vikrant Life Sciences Pvt. Ltd., Vitapure Corp., B. Braun Melsungen AG, and Otsuka Holdings Co. Ltd.. Also, the intravenous iv solutions market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global intravenous (IV) solutions market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global intravenous (iv) solutions market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Partial parenteral nutrition - Market size and forecast 2022-2027
Exhibit 34: Chart on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%)
6.4 Total parenteral nutrition - Market size and forecast 2022-2027
Exhibit 38: Chart on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Total parenteral nutrition - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Total parenteral nutrition - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacy - Market size and forecast 2022-2027
Exhibit 56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 60: Market opportunity by Distribution Channel ($ million)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2022-2027
Exhibit 67: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.4 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Amanta Healthcare Ltd.
Exhibit 111: Amanta Healthcare Ltd. - Overview
Exhibit 112: Amanta Healthcare Ltd. - Product / Service
Exhibit 113: Amanta Healthcare Ltd. - Key offerings
12.4 Axa Parenterals Ltd.
Exhibit 114: Axa Parenterals Ltd. - Overview
Exhibit 115: Axa Parenterals Ltd. - Product / Service
Exhibit 116: Axa Parenterals Ltd. - Key offerings
12.5 B. Braun Melsungen AG
Exhibit 117: B. Braun Melsungen AG - Overview
Exhibit 118: B. Braun Melsungen AG - Business segments
Exhibit 119: B. Braun Melsungen AG - Key news
Exhibit 120: B. Braun Melsungen AG - Key offerings
Exhibit 121: B. Braun Melsungen AG - Segment focus
12.6 Baxter International Inc.
Exhibit 122: Baxter International Inc. - Overview
Exhibit 123: Baxter International Inc. - Business segments
Exhibit 124: Baxter International Inc. - Key news
Exhibit 125: Baxter International Inc. - Key offerings
Exhibit 126: Baxter International Inc. - Segment focus
12.7 Fresenius SE and Co. KGaA
Exhibit 127: Fresenius SE and Co. KGaA - Overview
Exhibit 128: Fresenius SE and Co. KGaA - Business segments
Exhibit 129: Fresenius SE and Co. KGaA - Key news
Exhibit 130: Fresenius SE and Co. KGaA - Key offerings
Exhibit 131: Fresenius SE and Co. KGaA - Segment focus
12.8 Grifols SA
Exhibit 132: Grifols SA - Overview
Exhibit 133: Grifols SA - Business segments
Exhibit 134: Grifols SA - Key offerings
Exhibit 135: Grifols SA - Segment focus
12.9 ICU Medical Inc.
Exhibit 136: ICU Medical Inc. - Overview
Exhibit 137: ICU Medical Inc. - Product / Service
Exhibit 138: ICU Medical Inc. - Key offerings
12.10 JW Pharmaceutical Corp.
Exhibit 139: JW Pharmaceutical Corp. - Overview
Exhibit 140: JW Pharmaceutical Corp. - Product / Service
Exhibit 141: JW Pharmaceutical Corp. - Key offerings
12.11 Otsuka Holdings Co. Ltd.
Exhibit 142: Otsuka Holdings Co. Ltd. - Overview
Exhibit 143: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 144: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 145: Otsuka Holdings Co. Ltd. - Segment focus
12.12 Pfizer Inc.
Exhibit 146: Pfizer Inc. - Overview
Exhibit 147: Pfizer Inc. - Product / Service
Exhibit 148: Pfizer Inc. - Key news
Exhibit 149: Pfizer Inc. - Key offerings
12.13 Salius Pharma Pvt. Ltd.
Exhibit 150: Salius Pharma Pvt. Ltd. - Overview
Exhibit 151: Salius Pharma Pvt. Ltd. - Product / Service
Exhibit 152: Salius Pharma Pvt. Ltd. - Key offerings
12.14 Sichuan Kelun Pharmaceutical Co. Ltd.
Exhibit 153: Sichuan Kelun Pharmaceutical Co. Ltd. - Overview
Exhibit 154: Sichuan Kelun Pharmaceutical Co. Ltd. - Product / Service
Exhibit 155: Sichuan Kelun Pharmaceutical Co. Ltd. - Key offerings
12.15 Soxa Formulations and Research Pvt. Ltd.
Exhibit 156: Soxa Formulations and Research Pvt. Ltd. - Overview
Exhibit 157: Soxa Formulations and Research Pvt. Ltd. - Product / Service
Exhibit 158: Soxa Formulations and Research Pvt. Ltd. - Key offerings
12.16 Terumo Group
Exhibit 159: Terumo Group - Overview
Exhibit 160: Terumo Group - Business segments
Exhibit 161: Terumo Group - Key news
Exhibit 162: Terumo Group - Key offerings
Exhibit 163: Terumo Group - Segment focus
12.17 Vifor Pharma Management Ltd.
Exhibit 164: Vifor Pharma Management Ltd. - Overview
Exhibit 165: Vifor Pharma Management Ltd. - Product / Service
Exhibit 166: Vifor Pharma Management Ltd. - Key news
Exhibit 167: Vifor Pharma Management Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global intravenous (iv) solutions market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Total parenteral nutrition - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Total parenteral nutrition - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Distribution Channel ($ million)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Amanta Healthcare Ltd. - Overview
Exhibits112: Amanta Healthcare Ltd. - Product / Service
Exhibits113: Amanta Healthcare Ltd. - Key offerings
Exhibits114: Axa Parenterals Ltd. - Overview
Exhibits115: Axa Parenterals Ltd. - Product / Service
Exhibits116: Axa Parenterals Ltd. - Key offerings
Exhibits117: B. Braun Melsungen AG - Overview
Exhibits118: B. Braun Melsungen AG - Business segments
Exhibits119: B. Braun Melsungen AG - Key news
Exhibits120: B. Braun Melsungen AG - Key offerings
Exhibits121: B. Braun Melsungen AG - Segment focus
Exhibits122: Baxter International Inc. - Overview
Exhibits123: Baxter International Inc. - Business segments
Exhibits124: Baxter International Inc. - Key news
Exhibits125: Baxter International Inc. - Key offerings
Exhibits126: Baxter International Inc. - Segment focus
Exhibits127: Fresenius SE and Co. KGaA - Overview
Exhibits128: Fresenius SE and Co. KGaA - Business segments
Exhibits129: Fresenius SE and Co. KGaA - Key news
Exhibits130: Fresenius SE and Co. KGaA - Key offerings
Exhibits131: Fresenius SE and Co. KGaA - Segment focus
Exhibits132: Grifols SA - Overview
Exhibits133: Grifols SA - Business segments
Exhibits134: Grifols SA - Key offerings
Exhibits135: Grifols SA - Segment focus
Exhibits136: ICU Medical Inc. - Overview
Exhibits137: ICU Medical Inc. - Product / Service
Exhibits138: ICU Medical Inc. - Key offerings
Exhibits139: JW Pharmaceutical Corp. - Overview
Exhibits140: JW Pharmaceutical Corp. - Product / Service
Exhibits141: JW Pharmaceutical Corp. - Key offerings
Exhibits142: Otsuka Holdings Co. Ltd. - Overview
Exhibits143: Otsuka Holdings Co. Ltd. - Business segments
Exhibits144: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits145: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits146: Pfizer Inc. - Overview
Exhibits147: Pfizer Inc. - Product / Service
Exhibits148: Pfizer Inc. - Key news
Exhibits149: Pfizer Inc. - Key offerings
Exhibits150: Salius Pharma Pvt. Ltd. - Overview
Exhibits151: Salius Pharma Pvt. Ltd. - Product / Service
Exhibits152: Salius Pharma Pvt. Ltd. - Key offerings
Exhibits153: Sichuan Kelun Pharmaceutical Co. Ltd. - Overview
Exhibits154: Sichuan Kelun Pharmaceutical Co. Ltd. - Product / Service
Exhibits155: Sichuan Kelun Pharmaceutical Co. Ltd. - Key offerings
Exhibits156: Soxa Formulations and Research Pvt. Ltd. - Overview
Exhibits157: Soxa Formulations and Research Pvt. Ltd. - Product / Service
Exhibits158: Soxa Formulations and Research Pvt. Ltd. - Key offerings
Exhibits159: Terumo Group - Overview
Exhibits160: Terumo Group - Business segments
Exhibits161: Terumo Group - Key news
Exhibits162: Terumo Group - Key offerings
Exhibits163: Terumo Group - Segment focus
Exhibits164: Vifor Pharma Management Ltd. - Overview
Exhibits165: Vifor Pharma Management Ltd. - Product / Service
Exhibits166: Vifor Pharma Management Ltd. - Key news
Exhibits167: Vifor Pharma Management Ltd. - Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings